Related references
Note: Only part of the references are listed.Early transmissibility assessment of the N501Y mutant strains of SARS-CoV-2 in the United Kingdom, October to November 2020
Kathy Leung et al.
EUROSURVEILLANCE (2021)
IgA dominates the early neutralizing antibody response to SARS-CoV-2
Delphine Sterlin et al.
SCIENCE TRANSLATIONAL MEDICINE (2021)
Reduced neutralization of SARS-CoV-2 B.1.1.7 variant by convalescent and vaccine sera
Piyada Supasa et al.
CELL (2021)
Sixteen novel lineages of SARS-CoV-2 in South Africa
Houriiyah Tegally et al.
NATURE MEDICINE (2021)
Phase I study of a multitargeted recombinant Ad5 PSA/MUC-1/brachyury-based immunotherapy vaccine in patients with metastatic castration-resistant prostate cancer (mCRPC)
Marijo Bilusic et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2021)
A Phase I Trial Using a Multitargeted Recombinant Adenovirus 5 (CEA/MUC1/Brachyury)-Based Immunotherapy Vaccine Regimen in Patients with Advanced Cancer
Margaret E. Gatti-Mays et al.
ONCOLOGIST (2020)
Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding
Roujian Lu et al.
LANCET (2020)
Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation
Daniel Wrapp et al.
SCIENCE (2020)
Targets of T Cell Responses to SARS-CoV-2 Coronavirus in Humans with COVID-19 Disease and Unexposed Individuals
Alba Grifoni et al.
CELL (2020)
Structure, Function, and Antigenicity of the SARS-CoV-2 Spike Glycoprotein
Alexandra C. Walls et al.
CELL (2020)
Characterization of the receptor-binding domain (RBD) of 2019 novel coronavirus: implication for development of RBD protein as a viral attachment inhibitor and vaccine
Wanbo Tai et al.
CELLULAR & MOLECULAR IMMUNOLOGY (2020)
Detection of SARS-CoV-2-Specific Humoral and Cellular Immunity in COVID-19 Convalescent Individuals
Ling Ni et al.
IMMUNITY (2020)
Structural Genomics of SARS-CoV-2 Indicates Evolutionary Conserved Functional Regions of Viral Proteins
Suhas Srinivasan et al.
VIRUSES-BASEL (2020)
Safety, tolerability, and immunogenicity of a recombinant adenovirus type-5 vectored COVID-19 vaccine: a dose-escalation, open-label, non-randomised, first-in-human trial
Feng-Cai Zhu et al.
LANCET (2020)
Focus on Receptors for Coronaviruses with Special Reference to Angiotensin-Converting Enzyme 2 as a Potential Drug Target - A Perspective
Thea Magrone et al.
ENDOCRINE METABOLIC & IMMUNE DISORDERS-DRUG TARGETS (2020)
Antibody responses to SARS-CoV-2 in patients with COVID-19
Quan-Xin Long et al.
NATURE MEDICINE (2020)
SARS-CoV-2 T cell immunity: Specificity, function, durability, and role in protection
Daniel M. Altmann et al.
SCIENCE IMMUNOLOGY (2020)
Phenotype and kinetics of SARS-CoV-2-specific T cells in COVID-19 patients with acute respiratory distress syndrome
Daniela Weiskopf et al.
SCIENCE IMMUNOLOGY (2020)
Robust T Cell Immunity in Convalescent Individuals with Asymptomatic or Mild COVID-19
Takuya Sekine et al.
CELL (2020)
ChAdOx1 nCoV-19 vaccine prevents SARS-CoV-2 pneumonia in rhesus macaques
Neeltje van Doremalen et al.
NATURE (2020)
SARS-CoV-2-specific T cell immunity in cases of COVID-19 and SARS, and uninfected controls
Nina Le Bert et al.
NATURE (2020)
A SARS-CoV-2 surrogate virus neutralization test based on antibody-mediated blockage of ACE2-spike protein-protein interaction
Chee Wah Tan et al.
NATURE BIOTECHNOLOGY (2020)
Severe Acute Respiratory Syndrome Coronavirus 2-Specific Antibody Responses in Coronavirus Disease Patients
Nisreen M. A. Okba et al.
EMERGING INFECTIOUS DISEASES (2020)
Rapid Generation of Neutralizing Antibody Responses in COVID-19 Patients
Mehul S. Suthar et al.
CELL REPORTS MEDICINE (2020)
Decreased Vector Gene Expression from E2b Gene-Deleted Adenovirus Serotype 5 Vaccines Intensifies Proinflammatory Immune Responses
Dionisia Quiroga et al.
CLINICAL AND VACCINE IMMUNOLOGY (2017)
Memory T cell responses targeting the SARS coronavirus persist up to 11 years post-infection
Oi-Wing Ng et al.
VACCINE (2016)
Use of adenovirus as a model system to illustrate a simple method using standard equipment and inexpensive excipients to remove live virus dependence on the cold-chain
M. Stewart et al.
VACCINE (2014)
The Coronavirus Nucleocapsid Is a Multifunctional Protein
Ruth McBride et al.
VIRUSES-BASEL (2014)
T cell responses to viral infections - opportunities for peptide vaccination
Sietske Rosendahl Huber et al.
FRONTIERS IN IMMUNOLOGY (2014)
Novel adenoviral vector induces T-cell responses despite anti-adenoviral neutralizing antibodies in colorectal cancer patients
Michael A. Morse et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2013)
An Ad5[E1-, E2b-]-HER2/neu vector induces immune responses and inhibits HER2/neu expressing tumor progression in Ad5 immune mice
E. S. Gabitzsch et al.
CANCER GENE THERAPY (2011)
Lack of Peripheral Memory B Cell Responses in Recovered Patients with Severe Acute Respiratory Syndrome: A Six-Year Follow-Up Study
Fang Tang et al.
JOURNAL OF IMMUNOLOGY (2011)
Anti-tumor immunotherapy despite immunity to adenovirus using a novel adenoviral vector Ad5 [E1-, E2b-]-CEA
Elizabeth S. Gabitzsch et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2010)
Shaping Successful and Unsuccessful CD8 T Cell Responses Following Infection
Maureen A. Cox et al.
JOURNAL OF BIOMEDICINE AND BIOTECHNOLOGY (2010)
Overcoming pre-existing adenovirus immunity by genetic engineering of adenovirus-based vectors
Sergey S. Seregin et al.
EXPERT OPINION ON BIOLOGICAL THERAPY (2009)
Immune responses to T-cell epitopes of SARS CoV-N protein are enhanced by N immunization with a chimera of lysosome-associated membrane protein
K. Yang et al.
GENE THERAPY (2009)
T-cell quality in memory and protection: implications for vaccine design
Robert A. Seder et al.
NATURE REVIEWS IMMUNOLOGY (2008)
Multifunctional TH1 cells define a correlate of vaccine-mediated protection against Leishmania major
Patricia A. Darrah et al.
NATURE MEDICINE (2007)
Long-lived memory T lymphocyte responses against SARS coronavirus nucleocapsid protein in SARS-recovered patients
Hui Peng et al.
VIROLOGY (2006)
HIV nonprogressors preferentially maintain highly functional HIV-specific CD8+ T cells
Michael R. Betts et al.
BLOOD (2006)
SARS coronavirus nucleocapsid immunodominant T-cell epitope cluster is common to both exogenous recombinant and endogenous DNA-encoded immunogens
V Gupta et al.
VIROLOGY (2006)
Characterization and application of monoclonal antibodies against N protein of SARS-coronavirus
B Shang et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2005)
HIV-1-specific cytotoxicity is preferentially mediated by a subset of CD8+ T cells producing both interferon-γ and tumor necrosis factor-α
M Lichterfeld et al.
BLOOD (2004)
Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis
I Hamming et al.
JOURNAL OF PATHOLOGY (2004)
Nucleocapsid-independent specific viral RNA packaging via viral envelope protein and viral RNA signal
K Narayanan et al.
JOURNAL OF VIROLOGY (2003)
Promoter strength in adenovirus transducing vectors: Down-regulation of the adenovirus E1A promoter in 293 cells facilitates vector construction
J Schaack et al.
VIROLOGY (2001)
Share Paper
